Quick Answer
Edwards Lifesciences Corp reported Common Stock Shares Outstanding of 580.70 million shares for the year ending 2025.
- Edwards Lifesciences Corp showed a decrease of -1.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: 113.10 million shares | Q3 2010: 114.10 million shares | Q1 2011: 114.80 million shares | Q2 2011: 114.90 million shares | Q3 2011: 114.20 million shares | Q1 2012: 114.00 million shares | Q2 2012: 115.30 million shares | Q3 2012: 116.00 million shares | Q1 2013: 113.50 million shares | Q2 2013: 112.20 million shares | Q3 2013: 109.40 million shares | Q1 2014: 105.30 million shares | Q2 2014: 106.00 million shares | Q3 2014: 106.90 million shares | Q1 2015: 107.50 million shares | Q2 2015: 107.40 million shares | Q3 2015: 107.70 million shares | Q1 2016: 211.90 million shares | Q2 2016: 212.70 million shares | Q3 2016: 213.70 million shares | Q1 2017: 210.40 million shares | Q2 2017: 211.10 million shares | Q3 2017: 211.60 million shares | Q1 2018: 210.70 million shares | Q2 2018: 209.20 million shares | Q3 2018: 209.10 million shares | Q1 2019: 208.40 million shares | Q2 2019: 207.90 million shares | Q3 2019: 208.50 million shares | Q1 2020: 206.50 million shares | Q2 2020: 621.40 million shares | Q3 2020: 622.90 million shares | Q1 2021: 621.80 million shares | Q2 2021: 623.10 million shares | Q3 2021: 624.20 million shares | Q1 2022: 621.40 million shares | Q2 2022: 619.80 million shares | Q3 2022: 619.40 million shares | Q1 2023: 606.00 million shares | Q2 2023: 607.90 million shares | Q3 2023: 606.50 million shares | Q1 2024: 602.40 million shares | Q2 2024: 602.30 million shares | Q3 2024: 589.80 million shares | Q1 2025: 586.20 million shares | Q2 2025: 587.90 million shares | Q3 2025: 580.70 million shares.
- Over the full 17 years of available data (2009 to 2025), Edwards Lifesciences Corp's Common Stock Shares Outstanding has grown by 922.4%.
- Historical annual values: Fiscal year 2025: 580.70 million shares | Fiscal year 2024: 588.60 million shares | Fiscal year 2023: 601.10 million shares | Fiscal year 2022: 608.30 million shares | Fiscal year 2021: 624.10 million shares | Fiscal year 2020: 624.30 million shares | Fiscal year 2019: 209.10 million shares | Fiscal year 2018: 207.70 million shares | Fiscal year 2017: 209.70 million shares | Fiscal year 2016: 211.60 million shares | Fiscal year 2015: 215.40 million shares | Fiscal year 2014: 107.80 million shares | Fiscal year 2013: 109.30 million shares | Fiscal year 2012: 114.30 million shares | Fiscal year 2011: 114.10 million shares | Fiscal year 2010: 115.00 million shares | Fiscal year 2009: 56.80 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: